Trial Condition(s):

Functional Gastrointestinal Disorders

Study to learn more about the onset of effect of Iberogast in patients suffering from abnormal stomach and intestine function

Bayer Identifier:

20984

ClinicalTrials.gov Identifier:

NCT04059783

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Several studies have been done on the efficacy of the herbal medicine Iberogast. In this study researcher want to learn more about the time needed for Iberogast to start to work after the patient took the drug. This study plans to enroll 300 adult male and female patients suffering from disturbance of stomach and intestine normal function and treated by their doctor with Iberogast drops. Patients will be asked to document on a diary card the changes of symptom severity of the stomach and intestine complaints and the time needed for the symptoms to improve after drug intake. At the end of the study the treating doctor and the patients will be asked about the overall changes of symptoms. In addition information on the safety of the drug and how well the drug is tolerated by the patients will be collected

Inclusion Criteria
At the discretion of physician under the instructions of Rome III criteria concerning functional gastrointestinal symptoms as well as the summary of product characteristics of Iberogast
Exclusion Criteria
Therapeutic necessity

Trial Summary

Enrollment Goal
272
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Iberogast (STW5, BAY98-7411)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Many locations

Many locations, Germany

Status
Completed
 

Trial Design